Showing 361-370 of 739 results for "".
What's Hot in Cosmeceuticals
https://practicaldermatology.com/topics/practice-management/whats-hot-in-cosmeceuticals/21430/The expanding variety of cosmeceuticals allows dermatologists to address the specific needs and desires of patients.High Risk SCC: What Factors Predict Recurrence and Metastasis?
https://practicaldermatology.com/topics/general-topics/PD1208_12-php/22609/Data shed light on risk factors associated with aggressive SCC, allowing dermatologists to identify and properly follow high-risk patients.DEI in Dermatology
https://practicaldermatology.com/conferences/asds-2022-annual-meeting/dei-in-dermatology/20143/Dermatology remains one of the least diverse medical specialties, says Jeanine Downie, MD. There have been small steps forward to improve diversity, equity, inclusion, and accessibility in recent years, such as the DREAM initiative from Allergan Aesthetics and skinbetter science. But there is stillDermWireTV: AcneAlly Launches, Rosacea Insights, MC2/EPI Collaboration
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-acneally-launches-rosacea-insights-mc2epi-collaboration/19849/Dennis Porto, MD and Riyaz Farhaad, MD have launched AcneAlly.com, an online service that allows patients access to a board certified dermatologist and a standardized approach to assessment and long-term monitoring. Julie Harper, MD discusses findings from “Beyond the visible: Rosacea and psoriasisNovel Treatments for Acne
https://practicaldermatology.com/topics/acne-rosacea/novel-treatments-for-acne/19761/Joshua Zeichner, MD discusses three new treatments now available in the acne treatment armamentarium. For patients with severe acne, a new low-dose isotretinoin in a micronized formulation allows for better absorption, even without food. Dr. Zeichner also discusses the benefits of a new topical retiNeurotoxins on the Horizon: Bonti and Beyond
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neurotoxins-on-the-horizon-bonti-and-beyond/20321/Allergan's acquisition of Bonti highlights the burgeoning potential of the injectable neurotoxin market.Injection Tip: Start Superiorly
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/injection-tip-start-superiorly/18358/When using fillers, start superiorly, says Cheryl Burgess, MD. The approach may optimize lift and allow patients to achieve correction with less filler than originally estimated, she says.Psoriasis PACT Launches with Pfizer Support
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-psoriasis-pact-launches-with-pfizer-support/19028/New Services Launched to Support Psoriasis Patients, Dermatologists; New Developments in Valeant's Bid for Allergan; Promising Results for a Topical for HyperhidrosisPearls for Management of Pediatric Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/pearls-pediatric-management-atopic-dermatitis/27122/At the recently held 2024 American Academy of Dermatology (AAD) Innovation Academy dermatologist Lisa Swanson, MD, FAAD, presented new insights into pediatric atopic dermatitis (AD), emphasizing its wide-ranging impact on children's health, including increased risks of food allergies, infections, anEmbracing AI
https://practicaldermatology.com/topics/practice-management/embracing-ai/20080/Artificial intelligence is something dermatologists should be embracing as augmented intelligence. Anthony Rossi, MD says this intelligence will allow us to better diagnose, assess, and treat patients with everything from acne to melanoma.